Kopran announces amalgamation scheme for streamlined operations

Kopran [BSE:KOPRAN] disclosed a draft scheme of amalgamation between Kopran Laboratories Limited (Transferor Company) and Kopran Limited (Transferee Company), effective January 1, 2025, subject to shareholder and regulatory approvals. The move aims to consolidate diverse businesses, streamline group structure, and reduce legal compliances. Under the proposed scheme, 100 equity shares of Kopran Limited will be issued for every 45 equity shares of Kopran Laboratories Limited. The authorized share capital will be INR 780,000,000.00 The company anticipates better resource pooling, improved shareholder value, and enhanced ability to tackle future market challenges from the merger. The proposed transaction also includes provisions for employee continuity and treatment of assets, liabilities, and tax obligations. The company has provided a link to its website, www.kopran.com/investors/amalgamation/, for additional details. The merger requires sanction from the National Company Law Tribunal and approvals from stakeholders.